London-based multinational digital health firm Babylon has sold almost all of its U.K. assets to digital health company eMed Healthcare U.K., a subsidiary of U,S, company eMed, after announcing in early August that its deal to merge with Swiss tech firm MindMaze was canceled.
Babylon Healthcare Services Limited, the piece of Babylon purchased by eMed and the bulk of what remained of Babylon...
Multinational digital health firm Babylon reported its previously announced business combination with digital neurotherapy company MindMaze is not moving forward, and it will pursue the sale of its U.K. business to third parties and exit its U.S. business.
In June, the company revealed that it accepted a take-private proposal from AlbaCore Capital on behalf of its affiliate company MindMaze,...
Multinational digital health firm Babylon announced it has accepted a take-private proposal from AlbaCore Capital on behalf of its affiliate digital-neurotherapy company MindMaze, which will transition Babylon from a publicly-traded company to a private entity.
Babylon and MindMaze, which makes game-like rehabilitation tools for neurological conditions and injuries, will form a global privately-...
Babylon's stock price fell sharply after it announced plans to take the multinational digital health firm private, less than two years after the company debuted on the New York Stock Exchange.
Babylon also entered into an agreement with AlbaCore Capital LLP for a secured term loan facility for up to $34.5 million to support the company's plans to delist.
In the first quarter, Babylon reported...
As more patients avoid primary care while retail chains and virtual care players push into the space, panelists at ViVE 2023 discussed the future of preventive medicine and whether digital health could improve access.
Ali Parsa, CEO and founder of digital health firm Babylon, said more primary care options are a positive for the healthcare system. The problems are "too vast" for one group to...
Editor's note: This article has been updated with additional context from Babylon.
Multinational digital health firm Babylon has had a tumultuous few years. Its revenue has increased, but it continues to lose money and its stock price has plummeted.
Ali Parsa, Babylon's CEO and founder, joined MobiHealthNews to discuss lessons Babylon has learned since going public in 2021 and where its focus...
Multinational digital health firm Babylon reported its third quarter revenue had grown to $288.9 million, a 3.9x year-over-year boost, thanks to an increase in its value-based care business primarily driven by growth in Medicare membership.
Babylon reported a loss of $89.9 million for the period, compared to a $66 million loss in Q3 2021. Adjusted earnings before interest, taxes, depreciation and...
Multinational digital health firm Babylon said it plans to sell its independent physician association business in California to focus on digital-first contracts.
Meritage Medical Network is a group of about 1,800 doctors who provide in-person care across six counties in northern and central California. Babylon said divesting from the network will allow the firm to focus on its core business model...
Babylon announced Thursday the digital health firm had hired Andrew Hine as vice president of the go-to-market team for Asia, Europe, the Middle East and Africa.
The company said he'll manage Babylon's contracts and partnerships and work to increase its offerings and services in those regions. Hine joins Babylon from Ernst & Young, where he was head of health for the Middle East and North...
Multinational digital health company Babylon reported second-quarter revenue of $265.4 million, compared with $57.5 million during the same period last year.
Growth was primarily driven by a rise in value-based care (VBC) revenue, which jumped 524% year-over-year, to $244.1 million in Q2 2022.
Babylon was also able to reduce its cost-of-care-delivery expense as a percentage of revenue from the...
_29.jpg?itok=kE8l48g_ "Businesspeople shaking hands.")
_28.jpg?itok=t3a_I28c "Businesspeople shaking hands.")
